Table 2 Clinical features and outcomes of PLA2R positive HBV-MN patients and idiopathic MN patients
From: Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
HBV-MN (7) | Idiopathic MN (71) | P value | |
|---|---|---|---|
Baseline clinical characteristics | |||
Gender(male/female) | 2/5 | 48/23 | 0.091 |
Age | 45 (31, 59) | 53 (42, 61) | 0.426 |
eGFR (ml/min/1.73m2) | 107.8 (102.1, 125.9) | 98.3 (86.0, 109.6) | 0.170 |
Urinary Pro (g/24h) | 4.97 (2.48, 9.48) | 4.74 (2.38, 8.09) | 0.727 |
Urine RBC (/μL) | 94.5 (71.7, 204.8) | 64.9 (17.1, 105.3) | 0.085 |
ALB (g/L) | 24.43±5.15 | 26.33±6.15 | 0.432 |
Hypocomplementemia, n (%) | 3/6 (50.0) | 12/60 (20.0) | 0.125 |
Remission without IS | 0.048 | ||
NIS-Remission, n (%) | 6 (85.7) | 31 (43.7) | |
NIS-NR, n (%) | 0 (0) | 6 (8.5) | |
IS, n (%) | 1 (14.3) | 34 (47.9) | |
Renal insufficiency, n (%) | 0 (0) | 8 (11.3) | 1.000 |